178 related articles for article (PubMed ID: 19364848)
1. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
Bourne CR; Bunce RA; Bourne PC; Berlin KD; Barrow EW; Barrow WW
Antimicrob Agents Chemother; 2009 Jul; 53(7):3065-73. PubMed ID: 19364848
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
3. The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors.
Beierlein JM; Deshmukh L; Frey KM; Vinogradova O; Anderson AC
Biochemistry; 2009 May; 48(19):4100-8. PubMed ID: 19323450
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.
Bourne CR; Wakeham N; Nammalwar B; Tseitin V; Bourne PC; Barrow EW; Mylvaganam S; Ramnarayan K; Bunce RA; Berlin KD; Barrow WW
Biochim Biophys Acta; 2013 Jan; 1834(1):46-52. PubMed ID: 22999981
[TBL] [Abstract][Full Text] [Related]
6. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
Barrow EW; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Bourne CR; Barrow EW; Bunce RA; Bourne PC; Berlin KD; Barrow WW
Antimicrob Agents Chemother; 2010 Sep; 54(9):3825-33. PubMed ID: 20606069
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase.
Muddala NP; White JC; Nammalwar B; Pratt I; Thomas LM; Bunce RA; Berlin KD; Bourne CR
Eur J Med Chem; 2020 Aug; 200():112412. PubMed ID: 32502861
[TBL] [Abstract][Full Text] [Related]
11. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
12. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
[TBL] [Abstract][Full Text] [Related]
13. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
Beierlein JM; Karri NG; Anderson AC
J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.
Nammalwar B; Bunce RA; Berlin KD; Bourne CR; Bourne PC; Barrow EW; Barrow WW
Eur J Med Chem; 2012 Aug; 54():387-96. PubMed ID: 22703705
[TBL] [Abstract][Full Text] [Related]
15. Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative.
Popov VM; Chan DC; Fillingham YA; Atom Yee W; Wright DL; Anderson AC
Bioorg Med Chem Lett; 2006 Aug; 16(16):4366-70. PubMed ID: 16750361
[TBL] [Abstract][Full Text] [Related]
16. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
17. Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis.
Nammalwar B; Bourne CR; Wakeham N; Bourne PC; Barrow EW; Muddala NP; Bunce RA; Berlin KD; Barrow WW
Bioorg Med Chem; 2015 Jan; 23(1):203-11. PubMed ID: 25435253
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.
Nammalwar B; Bourne CR; Bunce RA; Wakeham N; Bourne PC; Ramnarayan K; Mylvaganam S; Berlin KD; Barrow EW; Barrow WW
ChemMedChem; 2012 Nov; 7(11):1974-82. PubMed ID: 22930550
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2,4-diaminopyrimidine-based antifolate drugs against Bacillus anthracis.
Nammalwar B; Muddala NP; Bourne CR; Henry M; Bourne PC; Bunce RA; Barrow EW; Berlin KD; Barrow WW
Molecules; 2014 Mar; 19(3):3231-46. PubMed ID: 24642909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
